Showing results (1-10 of 2,566) with videos related to
Sort By:
Pageof 257
JAMA|May 5, 1978
Circulating thrombin time anticoagulant in a procainamide-induced syndromeD K Galanakis, J Newman, D SummersThrombosis Research|May 15, 1995
Plasma cryoprecipitation studies: major increase in fibrinogen yield by albumin enrichment of plasmaD K GalanakisHematology/Oncology Clinics of North America|October 1, 1992
Fibrinogen anomalies and disease. A clinical updateD K GalanakisSeminars in Thrombosis and Hemostasis|January 1, 1992
Anticoagulant albumin fragments that bind to fibrinogen/fibrin: possible implicationsD K GalanakisThe Journal of Clinical Investigation|January 1, 1994
A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogenD K Galanakis, B GhebrehiwetBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1990
Fibrinogen Stony Brook II: partial characterization of a heterozygously transmitted peptide A anomalyD K Galanakis, M HultinBehring Institute Mitteilungen|December 1, 1993
C1q inhibitor (chondroitin-4-sulfate proteoglycan): structure and functionB Ghebrehiwet, D K GalanakisThe Journal of Laboratory and Clinical Medicine|March 1, 1983
Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivativesE I Peerschke, D K GalanakisBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1996
Platelet adhesion to late fibrinogen degradation productsE I Peerschke, D K GalanakisPageof 257